Roopa Industries Reports Growth Amid Financial Challenges in Recent Evaluation Adjustment
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid positive financial results for the quarter ending September 2024. The company reported significant net sales growth and a profit after tax, although it faces challenges related to long-term financial metrics and high debt levels.
Roopa Industries, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation adjustment reflecting its current market dynamics. The company reported positive financial performance for the quarter ending September 2024, with net sales for the first nine months reaching Rs 82.20 crore, showcasing a notable growth rate. Additionally, the profit after tax for the same period stood at Rs 1.31 crore, indicating a favorable trend in profitability.The stock's technical indicators suggest a mildly bullish range, with improvements noted in various metrics such as the Relative Strength Index (RSI) and Bollinger Bands. Despite these positive signals, Roopa Industries faces challenges, including a long-term average Return on Capital Employed (ROCE) of 5.09%, which indicates some weaknesses in fundamental strength. Furthermore, the company's high Debt to EBITDA ratio of 7.12 times raises concerns regarding its ability to service debt.
Overall, the recent evaluation adjustment reflects a complex picture of Roopa Industries, balancing positive short-term performance against longer-term financial challenges.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
